glp 1 drugs for sleep apnea Tirzepatide (Zepbound) – A New Treatment Obstructive Sleep Apnea and Obesity — Do GLP-1 Drugs Cure Sleep
Description
Introduction Although bone mineral density (BMD) is normal or even elevated in individuals with type 2 diabetes mellitus (T2D), T2D has been associated with an increased fracture risk ( Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and dipeptidyl peptidase 4 inhibitors (DPP-4i) were both introduced in Denmark in 2007, and new drugs in the classes are continually being introduced ( Knowledge about the impact of GLP-1 RAs on bone health and fracture risk is limited
She cited GLP-1 receptor agonists as a key therapy that can promote weight loss and benefit multiple conditions
Conclusion In summary, there is strong evidence from clinical trials for the use of GLP-1 RAs in the management of T2DM in people living with CKD
FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition
These include nausea, diarrhea, vomiting, and constipation
